Emmaus Medical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: September 14, 2016
Pages: 19
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E404D574563EN
Leaflet:

Download PDF Leaflet

Emmaus Medical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Emmaus Medical, Inc. (Emmaus Medical), a subsidiary of Emmaus Life Sciences, Inc., is a pharmaceutical company that discovers, develops and commercializes treatments and therapies for rare diseases and conditions. The company’s NutreStore product is an L-glutamine powder which is used for the treatment for short bowel syndrome. Emmaus is headquartered in Torrance, California, the US.

Emmaus Medical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deal Details
Partnerships
Emmaus Medical Terminates Co-Development Agreement with CellSeed
Emmaus Medical Terminates Co-Promotion Agreement With EMD Serono For Zorbtive
Emmaus Medical Enters Into Joint Venture Agreement To Form Emmaus Medical Japan
Debt Offering
Emmaus Medical Completes Private Placement Of Convertible Notes Due 2013 For US$0.2 Million
Emmaus Medical Completes Private Placement Of Convertible Note Due 2013 For US$0.1 Million
Emmaus Medical Completes Private Placement Of Convertible Notes Due 2013 For US$0.5 Million
Acquisition
Afh Acquisition Acquires Emmaus Medical In Reverse Take Over Transaction
Emmaus Medical Acquires Remaining 2.67% Stake In Emmaus Medical Japan
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Key Facts
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Emmaus Medical, Inc., Deals By Therapy Area, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Emmaus Medical Terminates Co-Development Agreement with CellSeed
Emmaus Medical Terminates Co-Promotion Agreement With EMD Serono For Zorbtive
Emmaus Medical Enters Into Joint Venture Agreement To Form Emmaus Medical Japan
Emmaus Medical Completes Private Placement Of Convertible Notes Due 2013 For US$0.2 Million
Emmaus Medical Completes Private Placement Of Convertible Note Due 2013 For US$0.1 Million
Emmaus Medical Completes Private Placement Of Convertible Notes Due 2013 For US$0.5 Million
Afh Acquisition Acquires Emmaus Medical In Reverse Take Over Transaction
Emmaus Medical Acquires Remaining 2.67% Stake In Emmaus Medical Japan
Emmaus Medical, Inc., Subsidiaries

LIST OF FIGURES

Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Emmaus Medical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Skip to top


Ask Your Question

Emmaus Medical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: